| High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability AK Croker, D Goodale, J Chu, C Postenka, BD Hedley, DA Hess, AL Allan Journal of cellular and molecular medicine 13 (8b), 2236-2252, 2009 | 656 | 2009 |
| Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation E van der Pol, A Sturk, T van Leeuwen, R Nieuwland, F Coumans, ... Journal of thrombosis and haemostasis 16 (6), 1236-1245, 2018 | 155 | 2018 |
| Tumor dormancy and metastasis BD Hedley, AF Chambers Advances in cancer research 102, 67-101, 2009 | 149 | 2009 |
| The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression BD Hedley, AL Allan, A Xenocostas Clinical cancer research 17 (20), 6373-6380, 2011 | 123 | 2011 |
| Technical issues: flow cytometry and rare event analysis BD Hedley, M Keeney International journal of laboratory hematology 35 (3), 344-350, 2013 | 113 | 2013 |
| Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1 BD Hedley, DR Welch, AL Allan, W Al‐Katib, DW Dales, CO Postenka, ... International journal of cancer 123 (3), 526-534, 2008 | 77 | 2008 |
| The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms EB Schulze, BD Hedley, D Goodale, CO Postenka, W Al-Katib, AB Tuck, ... Breast cancer research and treatment 112, 243-254, 2008 | 62 | 2008 |
| BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation BD Hedley, KS Vaidya, P Phadke, L MacKenzie, DW Dales, CO Postenka, ... Clinical & experimental metastasis 25, 727-740, 2008 | 59 | 2008 |
| Initial performance evaluation of the UniCel® DxH 800 Coulter® cellular analysis system BD Hedley, M Keeney, I Chin‐Yee, W Brown International Journal of Laboratory Hematology 33 (1), 45-56, 2011 | 48 | 2011 |
| A QA program for MRD testing demonstrates that systematic education can reduce discordance among experienced interpreters M Keeney, BL Wood, BD Hedley, JA DiGiuseppe, M Stetler‐Stevenson, ... Cytometry Part B: Clinical Cytometry 94 (2), 239-249, 2018 | 38 | 2018 |
| Novel lymphocyte screening tube using dried monoclonal antibody reagents BD Hedley, M Keeney, J Popma, I Chin‐Yee Cytometry Part B: Clinical Cytometry 88 (6), 361-370, 2015 | 37 | 2015 |
| Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth BD Hedley, AL Allan, AF Chambers Future Medicine Ltd 2 (5), 627-641, 2006 | 34 | 2006 |
| Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern C Voss, S Esmail, X Liu, MJ Knauer, S Ackloo, T Kaneko, L Lowes, ... JCI insight 6 (13), 2021 | 33 | 2021 |
| Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models BD Hedley, JE Chu, DG Ormond, MS Beausoleil, A Boasie, AL Allan, ... Clinical Cancer Research 17 (19), 6151-6162, 2011 | 33 | 2011 |
| User‐defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system LE Lowes, BD Hedley, M Keeney, AL Allan Cytometry Part A 81 (11), 983-995, 2012 | 32 | 2012 |
| Determination of optimal replicate number for validation of imprecision using fluorescence cell‐based assays: Proposed practical method BH Davis, CE McLaren, AJ Carcio, L Wong, BD Hedley, M Keeney, ... Cytometry Part B: Clinical Cytometry 84 (5), 329-337, 2013 | 31 | 2013 |
| Therapeutic targets for antimetastatic therapy BD Hedley, E Winquist, AF Chambers Expert opinion on therapeutic targets 8 (6), 527-536, 2004 | 31 | 2004 |
| The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis JL Townson, IC MacDonald, KT Liby, L Mackenzie, DW Dales, BD Hedley, ... Clinical & experimental metastasis 28, 309-317, 2011 | 28 | 2011 |
| Implementation of an NGS‐based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies MA Levy, S Santos, J Kerkhof, A Stuart, E Aref‐Eshghi, F Guo, B Hedley, ... European journal of haematology 103 (3), 178-189, 2019 | 25 | 2019 |
| Flow cytometry—Recognizing unusual populations in leukemia and lymphoma diagnosis M Keeney, BD Hedley, IH Chin‐Yee International journal of laboratory hematology 39, 86-92, 2017 | 22 | 2017 |
Alison L. AllanProfessor, Anatomy & Cell Biology and Oncology, University of Western OntarioVerified email at lhsc.on.ca
